FDA Adverse Event Injury Summary report: N

XCELA

MDR report key: 23057161 · Received September 15, 2025

Report

Report Number
3008737795-2025-00020
Event Type
Injury
Date Received
September 15, 2025
Date of Event
August 11, 2023
Report Date
September 15, 2025
Manufacturer
PFM MEDICAL CPP SA
Product Code
LJT
PMA / PMN Number
K072481
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

WITHOUT PRODUCT REFERENCE/BATCH # AND RETURN PRODUCT, THE MANUFACTURER COULD NOT CONDUCT NEITHER PRODUCT INVESTIGATION NOR DOCUMENTARY REVIEW. THEREFORE, IT IS NOT POSSIBLE TO CONFIRM THE REPORTED DEFECT "PURULENT DISCHARGE/INFECTION". THE RELATED RISK IS IDENTIFIED IN OUR RISK MANAGEMENT FILE. THEREFORE, COMPLAINT IS CLASSIFIED AS NO DEFINITIVE CONCLUSION, UNVERIFIABLE (NO RETURN PRODUCT).

Description of Event or Problem · 0

ON OR ABOUT (B)(6) 2023, PATIENT UNDERWENT PLACEMENT OF AN ANGIODYNAMICS XCELA PRODUCT, MODEL NUMBER H965451270. THE DEVICE WAS IMPLANTED AT (B)(6) HOSPITAL, (B)(6). ON OR ABOUT (B)(6) 2023, PATIENT PRESENTED AT (B)(6) HOSPITAL, WITH DISCHARGE FROM THE PORT SITE. ON OR ABOUT (B)(6) 2023, PATIENTS PORT WAS REMOVED BY DR. (B)(6) AT (B)(6) HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1398561 XCELA PORT LJT PFM MEDICAL CPP SA UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention